Latest Research Publications - Life Science Network

Heads up!

This list contains publications from the last 7 days only, with a maximum of 10,000 items. Use the search function to access older publications.

The default sorting of articles in this list is by the date when the article was uploaded or imported to our database (shown on top). Publication date is indicated below the title.

Created 19 Jun 2026

Stiffness-Activated Stellate Cells Drive Pancreatic Cancer Liver Colonization via GMFG-TNS4 Signaling.

by Biwen Zhu, Jian Wan, Xue Zhang, Jiashuai Yan, Xi Chen, Xiaoqi Guan, Qianqian Ren, Tao Yang, Di Wu, Qingsong Guo, Yibing Guo, Yuhua Lu — Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e76173. Jun 18, 2026.
- Views 7
- More stats
- - Report or request
Created 19 Jun 2026

HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.

by Yi Zeng, Zhenkun Huang, Jiliang Qiu, Guifang Yuan, Shaoru Liu, Jianxing Zhang, Liang Qiao, Zongfeng Wu, Dinglan Zuo, Shanshan Huang, Yu Li, Yichuan Yuan, Wei He, Binkui Li, Yunfei Yuan, Chenwei Wang, Yi Niu — Cancer research. Jun 18, 2026.
- Views 3
- More stats
- - Report or request
Created 19 Jun 2026

Viral Pleomorphism: How Virion Structure Guides Infection and Adaptation.

by Edward A Partlow, Callie J Donahue, Balindile B Motsa, Tijana Ivanovic — Annual review of virology. Jun 18, 2026.
- Views 5
- More stats
- - Report or request
Created 19 Jun 2026

Killer Peptide: An antibody-derived self-assembling peptide bridging antimicrobial and host-defense mechanisms.

by Miguel Fernandez de Ullivarri, Colin O'Sullivan, R Paul Ross, Colin Hill — FEMS microbiology reviews. Jun 18, 2026.
- Views 3
- More stats
- - Report or request
Created 19 Jun 2026

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase II single arm, open label trial.

by Carmela De Santo, Aimee Jackson, Francis Mussai, Saly Al-Taei, Neeraj Lal, Thomas Starkey, Livingstone Fultang, Nicola McJannett, Victoria Kunene, Lucinda Billingham, Anna Lawson, Su Lee, Joseph Rogers, Gary Middleton — Journal of leukocyte biology. Jun 18, 2026.
- Views 3
- More stats
- - Report or request
Created 19 Jun 2026

Klotho suppresses cyst growth in ADPKD through the regulation of ferroptosis and reversing DNA methylation.

by Jiayi Lv, Cheng Xue, Linda Xiaoyan Li, Lei Bu, Changlin Mei, Xiaogang Li — Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Jun 18, 2026.
- Views 5
- More stats
- - Report or request
Created 19 Jun 2026

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

by Christina M Lockwood, Hans J Messersmith, Annette S Kim, Padma Sheila Rajagopal, Umang Swami, Rena Xian, Dara Aisner, Maria E Arcila, Florence Kurttila, Christine M Lovly, Jason D Merker, Kanika G Nair, Atara Isaiah Ntekim, Melanie Anne Sheen, Apostolia Maria Tsimberidou, Nicholas C Turner, Stacy W Gray — JCO oncology practice. Pages OP2600311. Jun 18, 2026.
- Views 14
- More stats
- - Report or request
Created 19 Jun 2026

Development of a Knowledge Map for Managing Symptoms of Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

by Li Shanshan, Cai Huili, Chen Mingxia, Liu Linglong, Li Xiaoxuan — Computers, informatics, nursing : CIN. Jun 19, 2026.
- Views 5
- More stats
- - Report or request
Created 19 Jun 2026

Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

by Garth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, Shadia Jalal, Hannah F Tavalire, Derek J Gyori, Julie A Moeller, Brian G Bazzell, Michael J Kelley, A Mark Fendrick, David A Elliott, Nithya Ramnath, Timothy P Hofer, Alex K Bryant — JCO oncology practice. Pages OP2501241. Jun 18, 2026.
- Views 4
- More stats
- - Report or request
Created 19 Jun 2026

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

by Naoto Takahashi, Yosuke Minami, Yuki Fujioka, Shigeki Ohtake, Yoshiko Atsuta, Mio Kurata, Takaaki Ono, Shinya Sato, Shingo Yano, Katsumichi Fujimaki, Takeshi Maeda, Yukiyasu Ozawa, Emiko Sakaida, Takeshi Kondo, Masahide Yamamoto, Noriyoshi Iriyama, Toshihiro Miyamoto, Hitoshi Kiyoi, Yasushi Miyazaki, Itaru Matsumura — Blood advances. Jun 18, 2026.
- Views 6
- More stats
- - Report or request